Heart Disease Clinical Trials in Baltimore

Showing 321-340 of 505 trials

Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study

NCT03170219

To determine if a strategy of early discharge using a novel subcutaneous delivery system for parenteral furosemide can improve clinical outcomes within 30 days of randomization (days alive and outside the hospital) compared to usual care.

Acute Heart FailureDecompensated Heart Failure

Adrian Hernandez11 participantsStarted Apr 2018

Atlanta, Georgia, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +13 more locations

COMPLETEDPhase 2< 1 mile

A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss

NCT00094562

The purpose of this study is to evaluate the safety and effectiveness of fish oil supplements in maintaining weight in people with disease-related weight loss and/or cachexia.

CancerCancer CachexiaChronic Obstructive Pulmonary Disease+2 more

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins25 participantsStarted Jun 2004

Baltimore, Maryland, United States

COMPLETEDPhase 4< 1 mile

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

NCT01587651

This is a Phase 4, multicenter, open-label (blinded Pharmacodynamic PD results), randomized, 3-arm, parallel-design study of subjects with stable Coronary Artery Disease CAD. This study will compare the PD effect of prasugrel 10 mg QD (once-daily) maintenance dose with ticagrelor 90 mg BID (twice daily) maintenance dose in subjects with stable CAD who have previously received ticagrelor loading does (LD) and maintenance dose (MD)..

Coronary Artery Disease

Daiichi Sankyo110 participantsStarted Mar 2012

Jacksonville, Florida, United States • Miami, Florida, United States • Port Orange, Florida, United States +10 more locations

Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study

A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

Heart Disease Trials in Other Cities

Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography

Diuretics and Dopamine in Heart Failure With Preserved Ejection Fraction

Initial Study of Fenoterol as a Treatment for Heart Failure

IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting

Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients

Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy

Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants

Stem Cell Injection to Treat Heart Damage During Open Heart Surgery

Vascular Inflammation in Psoriasis - Extension Study

Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree

CANVAS - CANagliflozin cardioVascular Assessment Study

MultiPoint Pacing IDE Study

An Assessment of the Glider Balloon in Complex Lesions

Global Non-interventional Heart Failure Disease Registry

Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)

Other Conditions in Baltimore